173 related articles for article (PubMed ID: 25287716)
1. miR-150 modulates cisplatin chemosensitivity and invasiveness of muscle-invasive bladder cancer cells via targeting PDCD4 in vitro.
Lei Y; Hu X; Li B; Peng M; Tong S; Zu X; Wang Z; Qi L; Chen M
Med Sci Monit; 2014 Oct; 20():1850-7. PubMed ID: 25287716
[TBL] [Abstract][Full Text] [Related]
2. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy.
Li H; Yu G; Shi R; Lang B; Chen X; Xia D; Xiao H; Guo X; Guan W; Ye Z; Xiao W; Xu H
Mol Cancer; 2014 Jan; 13():8. PubMed ID: 24423412
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4.
Fu WF; Chen WB; Dai L; Yang GP; Jiang ZY; Pan L; Zhao J; Chen G
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2565-72. PubMed ID: 27383306
[TBL] [Abstract][Full Text] [Related]
5. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
[TBL] [Abstract][Full Text] [Related]
6. MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4.
Ren W; Wang X; Gao L; Li S; Yan X; Zhang J; Huang C; Zhang Y; Zhi K
Mol Cell Biochem; 2014 May; 390(1-2):253-62. PubMed ID: 24609942
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4.
Ning FL; Wang F; Li ML; Yu ZS; Hao YZ; Chen SS
Diagn Pathol; 2014 Jul; 9():143. PubMed ID: 25012722
[TBL] [Abstract][Full Text] [Related]
8. MiR-503 promotes the migration and invasion of colorectal cancer cells by regulating PDCD4.
Li L; Zhang X; Yi Z; Liang X; Yin W; Li S
J BUON; 2018; 23(3):579-586. PubMed ID: 30003722
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin.
Zhang X; Zhang Y; Liu X; Fang A; Li P; Li Z; Liu T; Yang Y; Du L; Wang C
PLoS One; 2015; 10(11):e0143441. PubMed ID: 26599571
[TBL] [Abstract][Full Text] [Related]
10. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
[TBL] [Abstract][Full Text] [Related]
11. MiR-20a acted as a ceRNA of lncRNA PTENPL and promoted bladder cancer cell proliferation and migration by regulating PDCD4.
Zhong XL; Wang L; Yan X; Yang XK; Xiu H; Zhao M; Wang XN; Liu JX
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2955-2964. PubMed ID: 32271413
[TBL] [Abstract][Full Text] [Related]
12. Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.
Yang YC; Liu GJ; Yuan DF; Li CQ; Xue M; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1513-1519. PubMed ID: 30840273
[TBL] [Abstract][Full Text] [Related]
13. miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.
Tan X; Peng J; Fu Y; An S; Rezaei K; Tabbara S; Teal CB; Man YG; Brem RF; Fu SW
Breast Cancer Res; 2014 Sep; 16(5):435. PubMed ID: 25228385
[TBL] [Abstract][Full Text] [Related]
14. Suppression of HAX-1 induced by miR-325 resensitizes bladder cancer cells to cisplatin-induced apoptosis.
Li R; Zheng JZ; Huang X
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9303-9314. PubMed ID: 33015771
[TBL] [Abstract][Full Text] [Related]
15. MiR-155 inhibits proliferation and invasion by directly targeting PDCD4 in non-small cell lung cancer.
Liu F; Song D; Wu Y; Liu X; Zhu J; Tang Y
Thorac Cancer; 2017 Nov; 8(6):613-619. PubMed ID: 28842954
[TBL] [Abstract][Full Text] [Related]
16. Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis.
Liu S; Fang Y; Shen H; Xu W; Li H
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):756-62. PubMed ID: 23824073
[TBL] [Abstract][Full Text] [Related]
17. MiR-486-5p enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by induction of apoptosis and down-regulation of metastatic genes.
Salimian J; Baradaran B; Azimzadeh Jamalkandi S; Moridikia A; Ahmadi A
Urol Oncol; 2020 Sep; 38(9):738.e9-738.e21. PubMed ID: 32527702
[TBL] [Abstract][Full Text] [Related]
18. An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
Seiler R; Oo HZ; Tortora D; Clausen TM; Wang CK; Kumar G; Pereira MA; Ørum-Madsen MS; Agerbæk MØ; Gustavsson T; Nordmaj MA; Rich JR; Lallous N; Fazli L; Lee SS; Douglas J; Todenhöfer T; Esfandnia S; Battsogt D; Babcook JS; Al-Nakouzi N; Crabb SJ; Moskalev I; Kiss B; Davicioni E; Thalmann GN; Rennie PS; Black PC; Salanti A; Daugaard M
Eur Urol; 2017 Jul; 72(1):142-150. PubMed ID: 28408175
[TBL] [Abstract][Full Text] [Related]
19. The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization.
Wu S; Xu R; Zhu X; He H; Zhang J; Zeng Q; Wang Y; Zhao X
Aging (Albany NY); 2020 Nov; 12(24):25845-25864. PubMed ID: 33234721
[TBL] [Abstract][Full Text] [Related]
20. Serum LUCAT1 implicates the pathogenesis of muscle-invasive bladder cancer via targeting miR-199a-5p and miR-199b-5p.
Zhou Y; Song X; Li X; Li H; Peng Y
J Mol Histol; 2020 Oct; 51(5):583-591. PubMed ID: 32844284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
